-
Company Insights
New![]()
Innovation and Patenting activity of MiMedx Group Inc Q3 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of MiMedx Group Inc Q3 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
New![]()
Surgical Sutures Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Surgical Sutures Pipeline Market Report Overview Surgical sutures are used to hold tissues together after injury or surgery to enhance the natural healing process. They are commonly used on the skin, internal tissues, organs, and blood vessels. Sutures are available in absorbable and non-absorbable suture types. The surgical sutures pipeline market research report provides comprehensive information about the surgical sutures pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials...
-
Sector Analysis
New![]()
Tissue Engineered – Skin Substitutes Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
Tissue Engineered - Skin Substitutes Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within Wound Care Management therapeutic area. The model discusses in detail the impact of COVID-19 on Tissue Engineered - Skin Substitutes market for the year 2020 and beyond. The use of skin substitutes provides an alternative therapy to heal chronic wounds showing superior efficacy and, in some cases, similar cost-effectiveness compared to traditional treatments. The main objective...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BP-1002 in Refractory Acute Myeloid Leukemia
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BP-1002 in Refractory Acute Myeloid Leukemia Drug Details: BP-1002 is under development for the treatment...
-
Sector Analysis
![]()
Wound Care Management (WCM) Market Size, Trends and Analysis by Product Type, Region and Segment Forecast to 2033
Accessing the in-depth insights from the ‘Wound Care Management’ market report can help you: Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments. Identify your competitors' capabilities to stay ahead in the market. Identify segments and get an understanding of various stakeholders across different stages of the entire value chain. Anticipate changes in demand and adjust your business development strategies. Identify potential regions and countries for growth opportunities....
-
Company Profile
![]()
MiMedx Group Inc – Company Profile
MiMedx Group Inc (MiMedx) is pharmaceutical company. It develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental tissues, cleans and reassembles layers, and dehydrates the tissue to preserve the key elements associated with healing. MiMedx’s product delivers human extracellular matrix components for regeneration of damaged or diseased tissues. Its products modulate inflammation, reduce scar tissue formation,...
Add to Basket -
Product Insights
![]()
Artificial Disc Replacement Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Artificial Disc Replacement Systems Pipeline Market Report Overview Artificial disc replacement offers an alternative to spinal fusion for the patients who have chronic back pain from degenerative disc disease. It allows natural motion in the part of the spine where the disc is implanted and thus allows for an early return to function. The implant is designed so that it can withstand bending, compression and repeated loads during movement. The artificial disc replacement systems pipeline market research report provides comprehensive...
-
Product Insights
![]()
United States Tissue Engineered – Skin Substitutes Market Share
Tissue Engineered – Skin Substitutes (Wound Care Management) United States Market Share report provides quantitative market trends within the Wound Care Management therapeutic area. Robust methodologies ensure an accurate overview of the market to deliver a comprehensive and precise market analysis. It incorporates primary sources from both the demand and supply sides. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of the purchase, excluding weekends and holidays. Certain...
-
Product Insights
![]()
Wound Closure Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Wound Closure Devices Pipeline Market Report Overview Wound closure devices are used to close wounds that occur due to injuries or surgical procedures. The Wound Closure Devices pipeline market research report provides comprehensive information about the Wound Closure Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The report discusses the territories where the Wound Closure Devices pipeline market is present. It also provides...
-
Product Insights
![]()
MiMedx Group Inc Pipeline Insight and Competitive Landscape, 2023
MiMedx Group Inc (MiMedx) is pharmaceutical company. It develops, manufactures and markets regenerative biologics utilizing human placental allografts. The company provides products such as amniotic membrane, umbilical cord, placental ECM and amniotic fluid. It utilizes proprietary purion process that separates placental tissues, cleans and reassembles layers, and dehydrates the tissue to preserve the key elements associated with healing. MiMedx’s product delivers human extracellular matrix components for regeneration of damaged or diseased tissues. Its products modulate inflammation, reduce scar tissue formation,...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.